110
Participants
Start Date
April 1, 2025
Primary Completion Date
July 31, 2025
Study Completion Date
October 31, 2025
Labetalol
Labetalol is a beta-blocker commonly used to manage hypertension in pregnancy and postpartum. In this study, oral labetalol will be initiated at 200mg twice or three times daily and adjusted up to 2400 mg/day as needed for blood pressure control.
Nifedipine
Nifedipine is a calcium channel blocker commonly used to manage hypertension in pregnancy and postpartum. In this study, oral extended-release nifedipine will be initiated at 30mg once daily and adjusted up to 120mg/day as needed for blood pressure control.
University of California, Los Angeles
OTHER